| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 14 | +64.29% | -3.77% | +0.19% | -3.96% | -5.08% | — |
| 14d | 14 | +85.71% | -7.82% | -0.25% | -7.57% | -8.52% | — |
| 30d | 14 | +78.57% | -1.77% | +2.40% | -4.17% | -10.44% | — |
| 60d | 14 | +85.71% | -6.53% | +4.70% | -11.23% | -28.13% | — |
| 90d | 14 | +78.57% | +4.82% | +6.02% | -1.20% | -38.95% | — |
| 180d | 14(2 pending) | +83.33% | +15.41% | +11.62% | +3.79% | -66.47% | — |
| 1y | 14(4 pending) | +80.00% | -3.37% | +14.85% | -18.22% | -90.23% | — |
| 2y | 14(9 pending) | +100.00% | -22.31% | +41.95% | -64.26% | -64.75% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| IPSC CENTURY THERAPEUTICS, INC. | SALE See Remarks | 2,584 | $2.23 | $5.8K | 512,319 | Jun 12, 2026 | Jun 15, 2026 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE See Remarks | 524 | $2.11 | $1.1K | 514,903 | Jun 8, 2026 | Jun 9, 2026 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE See Remarks | 10,076 | $2.55 | $25.7K | 515,427 | Mar 12, 2026 | Mar 16, 2026 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE See Remarks | 479 | $2.54 | $1.2K | 525,503 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 265,000 | — | — | 265,000 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 135,000 | — | — | 525,982 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE See Remarks | 526 | $0.53 | $280 | 390,982 | Dec 8, 2025 | Dec 10, 2025 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE See Remarks | 539 | $0.50 | $270 | 391,508 | Sep 8, 2025 | Sep 10, 2025 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE See Remarks | 526 | $0.62 | $327 | 392,047 | Jun 9, 2025 | Jun 11, 2025 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Mar 11, 2025 | Mar 12, 2025 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 392,573 | Mar 11, 2025 | Mar 12, 2025 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE See Remarks | 2,360 | $0.62 | $1.5K | 272,573 | Mar 10, 2025 | Mar 12, 2025 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 586 | $2.50 | $1.5K | 274,933 | Jul 26, 2024 | Jul 31, 2024 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,600 | $2.52 | $4.0K | 275,519 | Jul 24, 2024 | Jul 25, 2024 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 200 | $2.50 | $500 | 277,119 | Jul 23, 2024 | Jul 25, 2024 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $2.84 | $14.2K | 277,319 | Jun 20, 2024 | Jun 24, 2024 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $3.00 | $15.0K | 282,319 | Jun 5, 2024 | Jun 6, 2024 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $3.00 | $15.0K | 287,319 | May 20, 2024 | May 21, 2024 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $3.12 | $15.6K | 292,319 | May 6, 2024 | May 7, 2024 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $3.10 | $15.5K | 297,319 | Apr 22, 2024 | Apr 24, 2024 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 146,000 | — | — | 146,000 | Mar 7, 2024 | Mar 11, 2024 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 24,000 | — | — | 302,319 | Mar 7, 2024 | Mar 11, 2024 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 318,750 | — | — | 318,750 | Apr 11, 2023 | Apr 13, 2023 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 175,000 | — | — | 175,000 | Feb 2, 2023 | Feb 6, 2023 ↗ | View → |
| IPSC CENTURY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 105,000 | — | — | 105,000 | Jan 25, 2022 | Jan 27, 2022 ↗ | View → |